Bio Vitos Pharma
SE0009320278 · Outside a trading venue
2 directors and managers of Bio Vitos Pharma have disclosed 2 transactions under MAR Article 19: 2 buys worth €4k and 0 sells worth €0, which reads as net buying. The most recent disclosed transaction was on 2023-12-07. The largest buy was Anna Klevby Dalgaard (Chairman of the Board of Directors) for €4k. See live cluster buys or start a free 14-day trial to get alerts when Bio Vitos Pharma insiders trade.
Insiders
2
Net flow
€4k
Bought
€4k
Sold
€0
Buy Bio Vitos Pharma
Pick a broker. We handle the signal, they handle execution.
Affiliate links — we may earn a referral fee if you sign up.
All disclosed transactions
| Date | Type | Insider | Shares | Price | Value |
|---|---|---|---|---|---|
| 2023-12-07 2y ago | BUY | Jesper Birgemo Chief Executive Officer (CEO)/Managing Directory | 2,940,209 | — | €0 |
| 2021-01-04 5y ago | BUY | Anna Klevby Dalgaard Chairman of the Board of Directors | 10,289 | €0.42 | €4k |